SCHEMBL1899724

SCHEMBL1899724

CCCCCCCCCCCCCCCC(=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](C=O)OC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
MAPK1 P28482 1/20 0.49
LMNA P02545 4/20 0.44
PRKCA P17252 5/20 0.44
PRKCE Q02156 2/20 0.44
PRKCQ Q04759 2/20 0.44
PRKCD Q05655 2/20 0.44
KDM4E B2RXH2 1/20 0.43
DUSP3 P51452 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.40
DGKA P23743 1/20 0.40
FAAH O00519 1/20 0.39
HPGD P15428 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5355667 1.00 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL2563584 1.00 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL789885 0.94 PRKCA (0.51) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL8179685 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL11506064 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL8201074 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL2129639 0.90 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL1534016 0.89 MAPT (0.48) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL9225414 0.85 MAPT (0.53) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL9227207 0.85 MAPT (0.53) MAPTMAPK1LMNAPRKCAPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5603940-A WITH MIXTURES OF FATTY ACID ESTERS OF GLUCOSE AND FATTY ACID ESTERS OF SUCROSE AS EMULSIFIERS L'OREAL (FR) 1997-02-18 US claimed
EP-0647443-B1 Oil in water emulsion usable for the preparation of a cream OREAL (FR) 1996-08-28 EP claimed
US-20260144729-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2026-05-28 US disclosed
EP-4626397-A1 COSMETIC COMPOSITION FOR CARING KERATIN MATERIAL L'OREAL (FR) 2025-10-08 EP disclosed
EP-4611719-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2025-09-10 EP disclosed
WO-2024113155-A1 COSMETIC COMPOSITION FOR CARING KERATIN MATERIAL L'OREAL (FR) 2024-06-06 WO disclosed
WO-2024092386-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2024-05-10 WO disclosed
WO-2024031596-A1 COMPOSITION FOR TREATING KERATIN FIBERS L'OREAL (FR) 2024-02-15 WO disclosed
US-20230390168-A1 COMPOSITION FOR CONDITIONING KERATIN MATERIALS L'OREAL (FR) 2023-12-07 US disclosed
EP-4236905-A1 COMPOSITION FOR CONDITIONING KERATIN MATERIALS L'OREAL (FR) 2023-09-06 EP disclosed
WO-2023141803-A1 COMPOSITION SUITABLE FOR HIGH CONTENT OF OIL L'OREAL (FR) 2023-08-03 WO disclosed
WO-2005048766-A2 TRANSPARENT OIL GELLING SYSTEM E-L MANAGEMENT CORP. (US) 2005-06-02 WO disclosed
US-20050118218-A1 Emulsion containing organosilicon-based portions of hollow spheres L'OREAL (FR) 2005-06-02 US disclosed
US-20050112161-A1 Transparent oil gelling system E-L MANAGEMENT CORP. 2005-05-26 US disclosed
US-20050048016-A1 Composition containing a silicone elastomer and a block silicone copolymer L'OREAL (FR) 2005-03-03 US disclosed
US-20040142008-A1 Composition containing fibers and polyurethane, methods L'OREAL (FR) 2004-07-22 US disclosed
US-20040096406-A1 Composition containing ascorbic acid compound and screening agent, method of use L'OREAL (FR) 2004-05-20 US disclosed
US-20030224060-A1 Polyester polyol nanocapsules, compositions thereof, and methods of use L'OREAL (FR) 2003-12-04 US disclosed
US-20020192250-A1 Composition containing fibers, spherical particles and platelets, and its uses L'OREAL (FR) 2002-12-19 US disclosed
US-5603940-A WITH MIXTURES OF FATTY ACID ESTERS OF GLUCOSE AND FATTY ACID ESTERS OF SUCROSE AS EMULSIFIERS L'OREAL (FR) 1997-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050048016-A1 Composition containing a silicone elastomer and a block silicone copolymer F12, SMCHD1, CCNB3 MAPT 3218/4885MAPK1 3053/4885LMNA 494/4885
US-20040096406-A1 Composition containing ascorbic acid compound and screening agent, method of use CA6, PROC, CUTA MAPT 374/4885MAPK1 433/4885LMNA 567/4885
US-20260144729-A1 A CLEANSING COMPOSITION SMURF1, CUTA, S100B MAPT 734/4885MAPK1 3052/4885LMNA 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.